Ignite Creation Date:
2024-05-05 @ 11:44 PM
Last Modification Date:
2024-10-26 @ 10:38 AM
Study NCT ID:
NCT01402063
Status:
COMPLETED
Last Update Posted:
2020-02-17
First Post:
2011-07-08
Brief Title:
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
Sponsor:
Brown University
Organization:
Brown University
Study Overview
Official Title:
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation A Randomized Phase II Study
Status:
COMPLETED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To obtain preliminary data in a randomized phase II study whether PPXRT improves progression-free survival as compared to temozolomideRT for patients with GBM without MGMT methylation
Detailed Description:
To evaluate the toxicities of PPXRT To evaluate neuro-cognitive functional assessments of patients with GBM receiving PPXRT To obtain preliminary data in a randomized phase II study whether PPXRT improves overall survival as compared to temozolomide RT for patients with GBM without MGMT methylation to facilitate planning a phase III study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None